期刊
DIAGNOSTICS
卷 11, 期 5, 页码 -出版社
MDPI
DOI: 10.3390/diagnostics11050782
关键词
autophagy; ATG5; prognosis; colorectal cancer
资金
- Ministry of Science and Technology MOST [108-2320-B-110008-MY3, 108-2320-B-075B-003]
- Kaohsiung Chang Gung Memorial Hospital [CMRPG8G1001]
- E-Da hospital [EDAHP110041]
Gene mutation and pathogenesis bacteria are highly associated with colorectal cancer (CRC) development and progression. Autophagy, especially the key component ATG5, plays a crucial role in CRC malignancy with implications for both overall and disease-free survival. Further studies on ATG5 may provide insights into its potential as a prognostic biomarker and therapeutic target for CRC patients.
Gene mutation and pathogenesis bacteria are highly associated with colorectal cancer (CRC) development and progression. Autophagy is a self-clearance pathway to degrade abnormal proteins and infected bacteria in cells. Autophagy plays a dual role in cancer development. Among the autophagy-related (ATG) proteins, ATG5 is the key component required for the core machinery of autophagy. However, the role of ATG5 in CRC malignancy remains unclear. Herein, we found that a high ATG5 protein level was correlated with poor overall survival (OS) and disease-free survival (DFS) of 118 patients with CRC. After stratification with demographic and clinicopathologic factors, a high ATG5 protein level was significantly correlated with unfavorable overall survival in female and elder (>60 year) CRC patients and tumor tissues with poor differentiation, late T stages (III + IV), whereas the ATG5 protein level was positively associated with the overall survival in CRC patients without lymph node invasion and radiation therapy. In contrast, a high ATG5 protein level was significantly associated with worse DFS in CRC patients with early stage of AJCC and no radiation therapy. In addition, colorectal cancer cells stably harboring small interfering RNA (siRNA) against ATG5 diminished the tumorsphere formation and sensitized cancer cells to chemotherapeutic agents. Taken together, our results suggest that ATG5 might be a prognostic biomarker for CRC and a potential therapeutic target for CRC patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据